BackgroundCheck.run
Search For

Daniel Kalman, 623243 Wake Robin Trl, Atlanta, GA 30341

Related to:
Lorraine E Kalman 74 Rinat P Kalman 44 Corey J Kalman 31 Paul Eric Kalman 43

Daniel Kalman Phones & Addresses

3243 Wake Robin Trl, Atlanta, GA 30341    770-4918393    310-8244855   

Chamblee, GA   

1280 S Barrington Ave #5, Los Angeles, CA 90025    310-4732279   

202 Panorama Dr, San Francisco, CA 94131    415-8244855   

154 Oxford Ln #1, San Bruno, CA 94066    415-5885020   

Get Report
Control this profile

Mentions for Daniel Kalman

Daniel Kalman resumes & CV records

Resumes

Daniel Kalman Photo 39

Founder At Audio Talk Online English School

Position:
Founder at Audio Talk Online English School
Location:
Los Angeles, California
Industry:
E-Learning
Work:
Audio Talk Online English School - Online since Jun 2011
Founder Tokyo English - Tokyo, Japan Jan 2011 - Mar 2011
Founder & English Language Consultant ABCKara - Tokyo, Japan Jan 2011 - Mar 2011
English Instructor AEON Nov 2009 - Dec 2010
Teacher of English Target Jun 2007 - Aug 2007
Executive Management Intern University of Oregon Housing Sep 2005 - Jun 2006
Resident Assistant Graduate Marketing Jul 2005 - Aug 2005
Advertising Coordinator Intern Cutting Edge Lawn Service Apr 1998 - Sep 2004
Owner & Operator
Education:
Fajr Center for the Arabic Language 2008 - 2008
Arabic Level 1 Certificate, Intensive Arabic University of Oregon 2004 - 2008
BS & BA, Business Administration and International Studies University of Oregon - Charles H. Lundquist College of Business 2004 - 2008
B.S., Honors Business Administration University of Oregon - International Studies Department 2004 - 2008
B.A., International Studies (Middle East focus) The Hebrew University 2006 - 2007
Study Abroad: B.A. International Studies; B.S. Business South Eugene High School 2000 - 2004
Skills:
HTML + CSS, Adobe Photoshop, Adobe Illustrator, MS Office Suite, Adobe Soundbooth, Adobe Dreamweaver, HTML, Microsoft Office, CSS, Photoshop
Interests:
Language (English, Japanese, Hebrew, Spanish, Arabic) Entrepreneurship Traveling Salsa Dancing Snowboarding Embracing Challenges Stepping Outside of my Comfort Zone
Honor & Awards:
3.95 GPA; Magna Cum Laude University of Oregon Honors Honors Business Program 1st place (with cash prize) - Business plan presentation - 2008 University of Oregon Venture Quest Competition Centurion Award - Reserved for top 1/2% of students Dean's List - Lunquist College of Business Director's List - Robert D. Clark Honors College Ultimate Staff Motivator Award - University of Oregon Housing Advanced Placement Scholar with Distinction - The College Board Invitation to dance at the World Latin Dance Cup based on performance at the 2010 Japan Salsa Congress
Languages:
English
Japanese
Spanish
Hebrew
Awards:
2010 World Latin Dance Cup team performance invitation
2010 Japan Salsa Congress Judges
Performance video: http://www.youtube.com/watch?v=w8zSp3LbG8A
Centurion Award
University of Oregon
• Reserved for top 1/2% of student GPA's
Dean's List
Lundquist College of Business
Director's List
Robert D. Clark Honors College
William J. & Mary Jayne Robert Scholar
• Merit based scholarship for college
W.A. "Pete" Brook Scholar
• Merit based scholarship for college
Oregon Consular Corps Scholar
• Merit based scholarship for college
Velma Scholl Scholar
• Merit based scholarship for college
Ultimate Staff Motivator Award
University of Oregon Housing Complex Director
Daniel Kalman Photo 40

Daniel Kalman

Daniel Kalman Photo 41

Professor At Emory University School Of Medicine

Location:
Greater Atlanta Area
Industry:
Research

Publications & IP owners

Us Patents

Kinase Inhibitors For Preventing Or Treating Pathogen Infection And Method Of Use Thereof

US Patent:
8268809, Sep 18, 2012
Filed:
Sep 5, 2007
Appl. No.:
12/439961
Inventors:
Daniel Kalman - Atlanta GA, US
William Bornmann - Missouri City TX, US
Assignee:
Emory University - Atlanta GA
M.D. Anderson Cancer Center - Houston TX
International Classification:
A01N 43/00
A01N 43/54
A61K 31/33
A61K 31/50
A61K 31/505
C07D 239/42
C07D 401/04
C07D 239/00
C07D 239/02
C07D 401/00
C07D 403/00
C07D 405/00
C07D 409/00
C07D 411/00
C07D 413/00
C07D 417/00
C07D 419/00
US Classification:
514183, 51425201, 514256, 514272, 544242, 544331
Abstract:
The present invention provides compositions and methods of use thereof to prevent and/or treat pathogenic infection. In particular, the present invention provides the use of kinase inhibitors to inhibit kinases that involve in pathogen-host cell interactions that are associated with or cause pathogenic infections, therefore, to effectively prevent and/or treat pathogenic infections with far less likely to engender resistance as compared to conventional antibiotics and anti-viral drugs. The present invention further provides the use of kinase inhibitors for the treatment of acute pathogenic infections for a short period of time to avoid toxicities that may caused by long term use of these kinase inhibitors.

Small Molecule Inhibitors Of Bacterial Dam Dna Methyltransferases

US Patent:
2010003, Feb 11, 2010
Filed:
Dec 6, 2005
Appl. No.:
11/720971
Inventors:
Xiaodong Cheng - Decatur GA, US
John R. Horton - Stone Mountain GA, US
Zhe Yang - Atlanta GA, US
Daniel Kalman - Atlanta GA, US
Xing Zhang - Decatur GA, US
Stanley Hattman - Rochester NY, US
Albert Jeltsch - Ritterhude, DE
International Classification:
A61K 31/427
G06G 7/60
C12N 9/10
A61P 31/04
US Classification:
514370, 703 11, 435193
Abstract:
Disclosed are compounds, crystal structures, data representations, methods of using, and methods of identifying compounds in relation to DNA methylation and inhibition of methylation. In embodiments, DNA methylation is by DNA-adenine methyltransferases (Dam). In an embodiment, compounds are used to treat a host suspected of infection by a pathogenic organism. In an embodiment, virulence of a pathogenic bacterium is modified by treatment with an agent capable of inhibiting a bacterial Dam enzyme. In an embodiment, compounds and methods are disclosed regarding Dam inhibitors.

Production Of Anti-Microbial Peptides

US Patent:
2010004, Feb 25, 2010
Filed:
Nov 20, 2007
Appl. No.:
12/515530
Inventors:
Bettina Bommarius - Atlanta GA, US
Melanie Sherman - Stone Mountain GA, US
Daniel Kalman - Atlanta GA, US
Xiadong Cheng - Decatur GA, US
International Classification:
A61K 38/16
C07K 14/00
C07H 21/04
C12N 15/63
C12N 5/00
C12P 21/06
US Classification:
514 12, 530350, 536 234, 4353201, 435325, 435 697
Abstract:
The present application provides methods of producing antimicrobial peptides (AMPs) in a cell, for example by expression a fusion protein that includes small ubiquitin related modifier (SUMO) and an AMP in the cell. Also provided are nucleic acid and protein sequences of SUMO-AMP fusion proteins, and kits that include such molecules.

Noscapine And Noscapine Analogs And Their Use In Treating Infectious Diseases By Tubulin Binding Inhibition

US Patent:
2011027, Nov 10, 2011
Filed:
Sep 4, 2009
Appl. No.:
13/061447
Inventors:
Cory Acuff - Lawrenceville GA, US
Daniel Kalman - Atlanta GA, US
Assignee:
Emory University - Atlanta GA
International Classification:
A61K 31/4355
A61K 31/5377
A61K 31/4725
A61K 31/506
A61K 39/395
A61K 31/7088
A61K 31/7105
A61K 38/21
A61K 31/7028
A61K 31/4353
A61K 31/407
A61K 31/545
A61K 38/02
A61K 31/397
A61K 31/43
A61K 31/65
A61K 31/7048
A61K 31/513
A61P 31/00
A61P 31/14
A61P 31/12
A61P 31/20
A61P 31/22
A61P 31/16
A61P 31/18
A61P 31/04
A61P 31/10
A61K 31/496
US Classification:
424 854, 514291, 51425303, 5142328, 514256, 4241311, 514 44 A, 514 44 R, 514 25, 51421004, 51421009, 514200, 514 31, 51421002, 514192, 514154, 514 24, 514 31, 51425407, 514274
Abstract:
Compositions and methods for treating or preventing infectious diseases, and inhibiting the ability of microbes to travel within mammalian cells, and inhibiting microbial replication, are disclosed. The compositions include various noscapine analogs, which are capable of blocking the movement of viruses and other microbes within mammalian and other cells by inhibiting the cytoplasmic transport mechanisms within the cells. The compositions described herein include an effective amount of the noscapine analogues described herein, along with a pharmaceutically acceptable carrier or excipient. The compositions can also include one or more additional antimicrobial compounds.

Compositions And Methods Of Use For Tyrosine Kinase Inhibitors To Treat Pathogenic Infection

US Patent:
2011028, Nov 17, 2011
Filed:
Dec 16, 2010
Appl. No.:
12/969659
Inventors:
Daniel KALMAN - Atlanta GA, US
William Gerard Bornmann - Missouri City TX, US
Patrick Michael Reeves - Atlanta GA, US
Alyson Irene Swimm - Decatur GA, US
International Classification:
A61K 31/506
A61K 31/5377
A61K 31/517
A61K 31/502
A61K 31/427
A61P 31/20
A61P 31/12
A61P 31/22
A61P 31/18
A61P 31/04
A61P 31/06
A61K 31/519
A61K 31/404
US Classification:
5142345, 51425218, 51426411, 5142358, 51425219, 51426622, 514248, 514369, 514414, 5142664
Abstract:
Compositions and methods are provided for using tyrosine kinase inhibitors to treat pathogenic infection. In particular, methods for using Abl-family tyrosine kinase inhibitors to treat pathogenic infection are provided. Infections to be treated according to the present invention include, particularly, those caused by microbial pathogens such as bacteria and viruses.

Kinase Inhibitors For Preventing Or Treating Pathogen Infection And Method Of Use Thereof

US Patent:
2012030, Nov 29, 2012
Filed:
Aug 3, 2012
Appl. No.:
13/566186
Inventors:
Daniel Kalman - Atlanta GA, US
William Bornmann - Missouri City TX, US
Assignee:
M.D. ANDERSON CANCER CENTER - Houston TX
EMORY UNIVERSITY - Atlanta GA
International Classification:
A61K 31/506
A61K 31/5377
A61K 31/437
A61K 31/5025
A61P 31/20
A61P 31/18
A61P 31/22
A61P 31/06
A61P 31/16
A61P 31/14
A61K 31/505
A61P 31/04
US Classification:
5142332, 514256, 51425218, 5142358, 514303, 514248
Abstract:
The present invention provides compositions and methods of use thereof to prevent and/or treat pathogenic infection. In particular, the present invention provides the use of kinase inhibitors to inhibit kinases that involve in pathogen-host cell interactions that are associated with or cause pathogenic infections, therefore, to effectively prevent and/or treat pathogenic infections with far less likely to engender resistance as compared to conventional antibiotics and anti-viral drugs. The present invention further provides the use of kinase inhibitors for the treatment of acute pathogenic infections for a short period of time to avoid toxicities that may caused by long term use of these kinase inhibitors.

Use Of Kinase Inhibitors To Manage Tuberculosis And Other Infectious Diseases

US Patent:
2018025, Sep 6, 2018
Filed:
Sep 16, 2016
Appl. No.:
15/760978
Inventors:
- Atlanta GA, US
Daniel Kalman - Atlanta GA, US
International Classification:
A61K 31/506
A61P 31/06
Abstract:
This disclosure relates to the use of kinase inhibitor to treat or prevent infectious diseases such as tuberculosis. In certain embodiments, this disclosure relates to treating or preventing an infectious disease comprising administering an effective amount of a kinase inhibitor or other compound disclosed herein to a subject in need thereof. In certain embodiments, the disclosure relates to methods of treating or preventing tuberculosis comprising administering a kinase inhibitor to a subject in need thereof. In certain embodiments, the subject is diagnosed with (Mtb) that is resistant to multiple antibiotic agents.

Possible Relatives

David B Kalman  Debbie C Kalman  Aaron J Kalman  Denise D Kalman  Dennis M Kalman  Eric Kalman  Erica P Kalman  Daniel G Last  Daniel J Johnson  Daniel W Stamps 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.